<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39341596</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-7780</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</Title><ISOAbbreviation>J Infect Chemother</ISOAbbreviation></Journal><ArticleTitle>90-Day outcomes in patients with severe COVID-19 pneumonia treated with invasive mechanical ventilation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1341-321X(24)00270-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiac.2024.09.018</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There are few reports detailing the prognostic factors of severe COVID-19 pneumonia requiring invasive ventilation. We investigated the long-term prognosis and evaluated which factors influenced outcomes in these patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data was reviewed from severe adult COVID-19 cases admitted to our hospital and treated with mechanical ventilation between February 1, 2020, and October 30, 2021. On admission to our hospital, comorbidities and laboratory findings were collected from clinical records. Prognostic information for 90 days after diagnosis was also obtained from hospitals where patients were transferred after their conditions stabilized.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Prognostic information was obtained in 133 patients, of which 106 were males (79.7 %). Of the 133 patients, 67 were discharged (51.5 %), 21 continued inpatient care (15.8 %), and 45 died (33.8 %). Age, Charlson Risk Index, and the number of patients on hemodialysis were significantly higher in the deceased group. There were no differences in therapeutic interventions between survivors and those who died except for a higher rate of muscle relaxant and vasopressor usage in the deceased group. Laboratory findings on admission showed significantly higher levels of BUN, creatinine, and serum Krebs von den Lungen 6 (KL-6), and significantly lower platelet counts, hemoglobin, and alanine aminotransferase in those who died. Multivariate analysis revealed that age, hemodialysis, lower platelet counts, and higher KL-6 were independent predictors for 90-day mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Older age, hemodialysis, lower platelet counts and high KL-6 on admission were identified as independent predictors of 90-day mortality in patients with respiratory failure due to severe COVID-19 under invasive mechanical ventilation.</AbstractText><CopyrightInformation>Copyright © 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mineshita</LastName><ForeName>Masamichi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan. Electronic address: m-mine@marianna-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishine</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Handa</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Takeo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishibashi</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawahata</LastName><ForeName>Kimito</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Allergology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunishima</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuchida</LastName><ForeName>Tomoya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takemura</LastName><ForeName>Hiromu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Microbiology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minoura</LastName><ForeName>Ayu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine. 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takita</LastName><ForeName>Mumon</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine. 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujitani</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine. 2-16-1, Sugao, Miyamae-ku, Kawasaki- City, Kanagawa, 216-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Internal Medicine COVID Management Team of St. Marianna University Hospital</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Infect Chemother</MedlineTA><NlmUniqueID>9608375</NlmUniqueID><ISSNLinking>1341-321X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Invasive ventilation</Keyword><Keyword MajorTopicYN="N">Long-term prognosis</Keyword><Keyword MajorTopicYN="N">Mortality-related risk factor</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39341596</ArticleId><ArticleId IdType="doi">10.1016/j.jiac.2024.09.018</ArticleId><ArticleId IdType="pii">S1341-321X(24)00270-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle>